Clinical advances in difficult to treat tumours are awaited at ESMO 2019


Few days left before the ESMO Congress 2019 - starting on Friday 27 September - Dr Markus Joerger from Kantonsspital St.Gallen, Switzerland,  gives a little preview of the main outcomes coming from the annual event. Beyond updates on how to treat 'big killers' in oncology, promising results are also expected for some difficult-to-treat malignancies for which few options of care are available. 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.